Kevin Prohaska DO, MPH, Captain (USPHS)

Dr. Kevin Prohaska is a medical officer in the Office of Good Clinical Practice (OGCP) within the FDA Office of the Commissioner. His work at OGCP includes serving as a senior medical policy analyst with a focus on human subjects' protections including issues related to informed consent and bioethics. Dr. Prohaska is a board certified Family Practice physician with a diverse professional background that includes academic, clinical, military, and regulatory medicine. Dr. Prohaska started his career in the Commissioned Corps in 2000 as a medical review officer for the FDA Office of New Drugs. From there he moved to the Office for Human Research Protections where he served as a medical policy analyst and as the acting Executive Director of the Secretary's Advisory Committee for Human Research Protections (SACHRP). In May 2008, Dr. Prohaska returned to the FDA to serve as the Director of the Division of Safety Compliance and was responsible for the Center for Drug Evaluation and Research (CDER) IRB compliance oversight program. Since May 2014, Dr. Prohaska has been at OGCP where he focuses the majority of his efforts on policy development related to human subjects' protections and bioethics.